Suppr超能文献

不同新型抗精神病药物(阿立哌唑和奥氮平)所致复发性急性喉肌张力障碍1例报告

A Case Report of Recurrent Acute Laryngeal Dystonia With Different Novel Antipsychotics: Aripiprazole and Olanzapine.

作者信息

Ibn Auf Anas, Mohammed Mohammed A, Wahhas Hasan

机构信息

Psychiatry, Erada and Mental Health Complex, Taif, SAU.

Psychiatry, Ministry of Health, Jeddah, SAU.

出版信息

Cureus. 2024 Jan 10;16(1):e52001. doi: 10.7759/cureus.52001. eCollection 2024 Jan.

Abstract

Acute laryngeal dystonia (ALD) is a rare side effect of antipsychotic medications, but it is a life-threatening condition. We are introducing the case of a 49-year-old Saudi single male, who has been known to have schizophrenia for the last 20 years. He developed three attacks of acute laryngeal dystonia owing to different antipsychotic medications. The first was because of haloperidol on a dose of 20 mg a day. After being treated for dystonia and stabilized physically, the patient received oral aripiprazole at a dose of 10 mg a day. Unfortunately, he developed acute laryngeal dystonia, and treatment had to be discontinued. The third attack of dystonia was two months later because of the use of olanzapine in a dose of only 5 mg/day. The patient was finally stabilized on quetiapine with no more side effects. This case highlights the importance of careful monitoring of patients who are receiving antipsychotic medications, even newer ones, to avoid, or treat, such a rare but serious side effect early.

摘要

急性喉肌张力障碍(ALD)是抗精神病药物罕见的副作用,但却是一种危及生命的病症。我们现介绍一名49岁的沙特单身男性病例,该患者在过去20年中一直患有精神分裂症。他因不同的抗精神病药物引发了三次急性喉肌张力障碍发作。第一次是由于每天服用20毫克氟哌啶醇。在接受肌张力障碍治疗并身体状况稳定后,患者开始每天口服10毫克阿立哌唑。不幸的是,他又出现了急性喉肌张力障碍,不得不停药。第三次肌张力障碍发作是在两个月后,原因是每天仅服用5毫克奥氮平。该患者最终使用喹硫平病情稳定,未再出现副作用。这个病例凸显了对接受抗精神病药物治疗的患者进行仔细监测的重要性,即使是新药,以便早期避免或治疗这种罕见但严重的副作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验